With member diabetes associations in 20+ countries in our region and many people with diabetes we are working and collaborating to improve diabetes outcomes
The most comprehensive review to date demonstrates both positive and negative implications of paediatric type 1 diabetes screening, although the detection processes are considered broadly acceptable and ethical https://t.co/WU1W5Tmez1 🔓 @EDENT1FI
Continuous glucose monitoring in early-stage #Type1Diabetes for screening, staging & monitoring: what’s promising, what’s missing, and what’s needed for regulatory qualification #CGM https://t.co/LmMTI7fliz 🔓 @alicelouisejane@BesserBesser
Join Life for a Child at this virtual event exploring progress in access to type 1 diabetes medicines, supplies, and care for childhood NCDs globally.
This is a free online event:
5 February 2026
5:45pm - 7:45 pm EDT (New York Time)
Register: https://t.co/QNdcXxXIkI
Enhancing nationwide awareness of cholesterol treatment in type 1 diabetes (ENACT‐T1D): an Australian multi‐centre survey of patients and clinicians - Lan - 2026 - Internal Medicine Journal - Wiley Online Library https://t.co/rMVE8le5Vy. Thanks all study participants+ coauthors
On 11 January, the global diabetes community honours one of the greatest breakthroughs in medical history: the first life‑saving insulin injection given to 14‑year‑old Leonard Thompson in 1922 transformed type 1 diabetes from a certain death sentence into a survivable condition.
#Webinar – Join us on 23 January for our online event on supporting students with #diabetes. Advocates & health experts will share insights, experiences and policy priorities to build inclusive, stigma-free schools. Learn more and register: https://t.co/6K2sMazXMd
Looking ahead to 2026: Our mission remains clear — ensure access to quality diabetes care for everyone, everywhere. Equity, innovation, and collaboration will guide every step we take.
Rethinking diabetes care for Indigenous Australians: the need for Indigenous‐codesigned and led diabetes models of care - Nanayakkara - 2025 - Medical Journal of Australia - Wiley Online Library https://t.co/jF9TXsqTzX
📉 Our comprehensive review of Medication Adherence published in @DiabetologiaJnl
Non-adherence affects ~38% of people T2 diabetes,
Leads to higher HbA1c, more micro/macrovascular complications, hospitalisations, mortality, and major healthcare costs.
🔍 Causes span patient, socioeconomic, condition-related & system factors.
💊 Effective strategies: pharmacist-led care, fixed-dose combinations, and tailored, multifaceted interventions.
Tech & motivational tools show mixed results.
🔑 Personalised, scalable solutions are urgently needed. #T2D #DiabetesCare #MedAdherence
Led by Patrick Highton
https://t.co/HucsOrnl9Z
With @mark_funnell @PankajLeicester@LeeLingLim1@scelee1@frazac
The Patient’s Voice
“I’m afraid I can’t afford insulin.”
“I hide my diagnosis out of shame.”
“I feel alone with my condition.”
These voices must never be forgotten.
🚨 Registrations are now OPEN for the International Diabetes Federation Western Pacific Region Congress 2026!
Be part of one of the region’s leading diabetes events and secure your place today!
🔗https://t.co/TVKLZEj0Pp…
No child should die of diabetes.
Since 2000, we have been working to change that, helping young people access the insulin, supplies and support they need to live.
This #WorldDiabetesDay, share this post to stand with us, as we work to make sure that no child is left behind.